FDA Approved: SPRAVATO — Original Application (Janssen Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved SPRAVATO (esketamine hydrochloride) nasal spray under an original NDA (NDA211243) for treatment-resistant depression in adults. The approval specif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

ORIG AP for SPRAVATO (ESKETAMINE HYDROCHLORIDE)